Bain BJ. Blood cells: a practical guide. 5th ed. Oxford: Wiley-Blackwell; 2015.
Wechsler ME. Pulmonary eosinophilic syndromes. Immunol Allergy Clin North Am. 2007;27:477-492.
Whetham J, Day JN, Armstrong M, et al. Investigation of tropical eosinophilia: assessing a strategy based on geographical area. J Infect. 2003;46:180-185.
Nutman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Immunol Allergy Clin North Am. 2007;27:529-549.
Bain BJ, Fletcher SH. Chronic eosinophilic leukemias and the myeloproliferative variant of the hypereosinophilic syndrome. Immunol Allergy Clin North Am. 2007;27:377-388.
Helbig G. Advances in the diagnosis and treatment of eosinophilia. Curr Opin Hematol. 2014;21:3-7.
Butt NM, Lambert J, Ali S, et al.; British Society for Haematology. Guideline for the investigation and management of eosinophilia. Br J Haematol. 2017;176:553–572.
1. Bain BJ. Blood cells: a practical guide. 5th ed. Oxford: Wiley-Blackwell; 2015.
2. Montgomery ND, Dunphy CH, Mooberry M, et al. Diagnostic complexities of eosinophilia. Arch Pathol Lab Med. 2013;137:259-269.
3. Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med. 2011;124:588-597.
4. Wechsler ME. Pulmonary eosinophilic syndromes. Immunol Allergy Clin North Am. 2007;27:477-492.
5. Checkley AM, Chiodini PL, Dockrell DH, et al. Eosinophilia in returning travellers and migrants from the tropics: UK recommendations for investigation and initial management. J Infect. 2010;60:1-20.
6. Ehrhardt S, Burchard GD. [Eosinophilia in returning travelers and migrants]. Dtsch Arztebl. 2008;105:801-807.
7. Whetham J, Day JN, Armstrong M, et al. Investigation of tropical eosinophilia: assessing a strategy based on geographical area. J Infect. 2003;46:180-185.
8. Bain BJ. Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1. Haematologica. 2010;95:696-698.
9. Rudzki Z, Giles L, Cross NC, et al. Myeloid neoplasm with rearrangement of PDGFRA, but with no significant eosinophilia: should we broaden the World Health Organization definition of the entity? Br J Haematol. 2012:156;558.
10. Bain BJ, Horny H-P, Hasserjian RP, et al. Chronic eosinophilic leukaemia, not otherwise specified. In: Swerdlow SH, Campo E, Harris NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: IARC Press; 2017:54-56
11. Nutman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Immunol Allergy Clin North Am. 2007;27:529-549.
12. Caruana SR, Kelly HA, Ngeow JY, et al. Undiagnosed and potentially lethal parasite infections among immigrants and refugees in Australia. J Travel Med. 2006 Jul-Aug;13(4):233-9.
14. Al Samman M, Haque S, Long JD. Strongyloidiasis colitis: a case report and review of the literature. J Clin Gastroenterol. 1999;28:77-80.
15. Checkley AM, Chiodini PL, Dockrell DH, et al; British Infection Society and Hospital for Tropical Diseases. Eosinophilia in returning travellers and migrants from the tropics: UK recommendations for investigation and initial management. J Infect. 2010;60:1-20.
16. Seybolt LM, Christiansen D, Barnett ED. Diagnostic evaluation of newly arrived asymptomatic refugees with eosinophilia. Clin Infect Dis. 2006 Feb 1;42(3):363-7.
17. Walker NI, Croese J, Clouston AD, et al. Eosinophilic enteritis in northeastern Australia: pathology, association with Ancylostoma caninum, and implications. Am J Surg Pathol. 1995;19:328-337.
18. Saubolle MA. Laboratory aspects in the diagnosis of coccidioidomycosis. Ann N Y Acad Sci. 2007;1111:301-314.
19. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest. 2009;135:805-826.
20. Hagen EC, Daha MR, Hermans J, et al; EC/BCR Project for ANCA Assay Standardization. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. Kidney Int. 1998;53:743-753.
21. Lucendo AJ, Molina-Infante J,Arias Á, et al. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United European Gastroenterol J. 2017;5(3): 335–358.
22. Chen JW, Kao JY. Eosinophilic esophagitis: update on management and controversies. BMJ 2017;359:j4482
23. Sperry SL, Shaheen NJ, Dellon ES. Toward uniformity in the diagnosis of eosinophilic esophagitis (EoE): the effect of guidelines on variability of diagnostic criteria for EoE. Am J Gastroenterol. 2011;106:824-832.
24. Chen M, Olson K. Colonic graft-versus-host disease (GVHD) manifesting as eosinophilic colitis following autologous hematopoietic stem cell transplantation. Blood. 2013;121:4020.
25. Wolpin BM, Weller PF, Katz JT, Levy BD, Loscalzo J. Clinical problem-solving. The writing on the wall. N Engl J Med. 2009 Oct 1;361(14):1387-92.
26. Wells GC. Recurrent granulomatous dermatitis with eosinophilia. Trans St Johns Hosp Dermatol Soc. 1971;57:46-56.
27. Bain BJ, Horny H-P, Arber DA, et al. Myeloid/lymphoid neoplasms with eosinophilia and rearrangements of PDGFRA, PDGFRB, FGFR1, or with PCM1-JAK2. In: Swerdlow SH, Campo E, Harris NL, et al., eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. IARC Press, Lyon; 2017:71–79.
28. Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003 Mar 27;348(13):1201-14.
29. Bain BJ, Fletcher SH. Chronic eosinophilic leukemias and the myeloproliferative variant of the hypereosinophilic syndrome. Immunol Allergy Clin North Am. 2007;27:377-388.
30. Helbig G. Advances in the diagnosis and treatment of eosinophilia. Curr Opin Hematol. 2014;21:3-7.
31. Bain BJ, Ahmad S. Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities? Br J Haematol. 2014;166:809-817.
32. Walz C, Erben P, Ritter M, et al. Response of ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3. Blood. 2011;118:2239-2342.
33. Stussi G, Tichelli A, Schanz U, et al. Hypereosinophilia with a low blast count as the initial manifestation of acute myeloid leukaemia with RUNX1-RUNX1T1. Br J Haematol. 2009;146:346.
34. Roufosse F. Hypereosinophilic syndrome variants: diagnostic and therapeutic considerations. Haematologica. 2009;94:1188-1193.
35. Butt NM, Lambert J, Ali S, et al.; British Society for Haematology. Guideline for the investigation and management of eosinophilia. Br J Haematol. 2017;176:553–572.
36. Chusid MJ, Dale DC, West BC, et al. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore). 1975;54:1-27.
38. O'Connell EM, Nutman TB. Eosinophilia in infectious diseases. Immunol Allergy Clin North Am. 2015;35:493-522.
39. Grimbacher B, Holland SM, Gallin JI, et al. Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. N Engl J Med. 1999;340:692-702.
40. Zhang Q, Davis JC, Lamborn IT, et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med. 2009;361:2046-2055.
41. Zhang Y, Yu X, Ichikawa M, et al. Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment. J Allergy Clin Immunol. 2014;133:1400-1409.
42. Williams KW, Milner JD, Freeman AF. Eosinophilia associated with disorders of immune deficiency or immune dysregulation. Immunol Allergy Clin North Am. 2015;35:523-544.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台